Notes - Segment Information, Etc.

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7256194

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Notes - Segment information, etc.
Segment information
Disclosure of sales, profit (loss), asset, liability, and other items for each reportable segment
Sales
Revenues from external customers
JPY
64,139,000,000 JPY
237,000,000 JPY
56,655,000,000 JPY
7,246,000,000 JPY
64,139,000,000 JPY
JPY
56,016,000,000 JPY
62,843,000,000 JPY
162,000,000 JPY
JPY
62,843,000,000 JPY
6,664,000,000 JPY
Transactions with other segments
JPY
88,000,000 JPY
88,000,000 JPY
JPY
JPY
JPY
-88,000,000 JPY
JPY
JPY
64,000,000 JPY
-64,000,000 JPY
64,000,000 JPY
JPY
Other items
Depreciation
JPY
1,696,000,000 JPY
JPY
1,693,000,000 JPY
3,000,000 JPY
1,889,000,000 JPY
192,000,000 JPY
2,227,000,000 JPY
2,432,000,000 JPY
JPY
201,000,000 JPY
2,231,000,000 JPY
4,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.